Alexei Agapitov is a Cardiology physician. OpenAlex indexes 11 publications with 322 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
700 S Park St Ste A
Madison, WI 537151830
Telephone
608-260-2900Provider last certified this registry record 10 Nov 2025.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- HEARTFLOW, INC.Program year202514 payments
- Amgen Inc.Program year20252 payments
- HEARTFLOW, INC.Program year20243 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
82.2%Statin19.8%Atorvastatin Calcium54%Rosuvastatin Calcium31%Pravastatin Sodium10%Simvastatin6%Part D≥167 patientsBeta blocker18.5%Metoprolol Succinate54%Carvedilol25%Metoprolol Tartrate14%Nebivolol Hcl2%Sotalol2%Bisoprolol Fumarate2%Atenolol1%Part D<11 patients+ 16 more classes in this area
Blood & clotting
12.5%Factor Xa inhibitor8.1%Eliquis86%Xarelto14%Part D≥90 patientsP2Y12 inhibitor2.2%Clopidogrel100%Part D≥38 patients+ 1 more class in this area
Metabolism & gastrointestinal
5.3%SGLT2 inhibitor3.7%Jardiance69%Farxiga31%Part D≥44 patientsPotassium supplement0.9%Potassium Chloride100%Part D≥13 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Sildenafil Increases Sympathetically Mediated Vascular Tone in Humans
American Journal of Hypertension
2013 - EVIDENCE THAT EDHF DEFICIENCY CONTRIBUTES TO ENDOTHELIAL DYSFUNCTION IN HUMAN ATHEROSCLEROSIS
Journal of Hypertension
2011 - Obesity does not increase sympathetic vascular tone in hypertensives
American Journal of Hypertension
2005
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”